Oral Clofarabine in Chronic Lymphocytic Leukemia (CLL)
Status:
Withdrawn
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to find the highest tolerable dose of clofarabine
when given to patients with CLL. The safety of this drug will also be studied.